+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Analgesics Market Research Reports

Topical Pain Relief Market Report and Forecast 2023-2031 - Product Thumbnail Image

Topical Pain Relief Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
Mexico Medical Cannabis Market Report and Forecast 2024-2032 - Product Thumbnail Image

Mexico Medical Cannabis Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 188 Pages
  • Mexico
From
Paracetamol Market Report and Forecast 2024-2032 - Product Thumbnail Image

Paracetamol Market Report and Forecast 2024-2032

  • Report
  • October 2023
  • 140 Pages
  • Global
From
Cannabis Market Report and Forecast 2023-2028 - Product Thumbnail Image

Cannabis Market Report and Forecast 2023-2028

  • Report
  • August 2023
  • 181 Pages
  • Global
From
Gabapentin Market Report and Forecast 2023-2031 - Product Thumbnail Image

Gabapentin Market Report and Forecast 2023-2031

  • Report
  • July 2023
  • 140 Pages
  • Global
From
Postoperative Pain Therapeutics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Postoperative Pain Therapeutics Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 140 Pages
  • Global
From
Medical Cannabis Market Report and Forecast 2023-2031 - Product Thumbnail Image

Medical Cannabis Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
Legal Marijuana Market Report and Forecast 2023-2031 - Product Thumbnail Image

Legal Marijuana Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 140 Pages
  • Global
From
Analgesics Market Report and Forecast 2023-2031 - Product Thumbnail Image

Analgesics Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Medical Marijuana Market Analysis & Forecast 2024-2034: Market By Product; By Application; By End-user; and By Region - Product Thumbnail Image

Medical Marijuana Market Analysis & Forecast 2024-2034: Market By Product; By Application; By End-user; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Opioid Use Disorder Market Analysis & Forecast 2024-2034: Market By Drug; By Age Group; By Route of Administration; By Distribution Channel; and By Region - Product Thumbnail Image

Opioid Use Disorder Market Analysis & Forecast 2024-2034: Market By Drug; By Age Group; By Route of Administration; By Distribution Channel; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Arthralgia (Joint Pain) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update - Product Thumbnail Image

Arthralgia (Joint Pain) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update

  • Report
  • August 2023
  • 367 Pages
  • Global
From
Chronic Low Back Pain (CLBP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Chronic Low Back Pain (CLBP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • May 2023
  • 74 Pages
  • Global
From
Opioid Use Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Opioid Use Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • February 2023
  • 70 Pages
  • Global
From
Diabetic Neuropathic Pain Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Diabetic Neuropathic Pain Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • February 2023
  • 127 Pages
  • Global
From
Painful Diabetic Neuropathy Epidemiology Analysis and Forecast, 2021-2031 - Product Thumbnail Image

Painful Diabetic Neuropathy Epidemiology Analysis and Forecast, 2021-2031

  • Report
  • February 2023
  • 32 Pages
  • Global
From
Opium (Opioid) Addiction Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Opium (Opioid) Addiction Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • April 2022
  • 560 Pages
  • Global
From
Migraine - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Migraine - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 985 Pages
  • Global
From
Migraine - Global Drug Forecast and Market Analysis to 2030 - Product Thumbnail Image

Migraine - Global Drug Forecast and Market Analysis to 2030

  • Report
  • November 2021
  • 131 Pages
  • Global
From
Pain: GPCR and Nerve Growth Factor-Based Therapies Offer Strong Potential in Difficult-to-Treat Subtypes - Product Thumbnail Image

Pain: GPCR and Nerve Growth Factor-Based Therapies Offer Strong Potential in Difficult-to-Treat Subtypes

  • Report
  • April 2019
  • 75 Pages
  • Global
From
Loading Indicator

The Analgesics market is a sector of the pharmaceutical industry that focuses on the production and sale of drugs used to relieve pain. Analgesics are used to treat a variety of conditions, including headaches, muscle pain, arthritis, and post-operative pain. Common analgesics include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen. Analgesics are available in a variety of forms, including tablets, capsules, liquids, and topical creams. Many analgesics are available over-the-counter, while others require a prescription. The analgesics market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the analgesics market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Merck. Show Less Read more